Prognostic Factors for Survival in Patients with Acute Invasive Fungal Rhinosinusitis

Background Acute invasive fungal rhinosinusitis (AIFR) is an aggressive opportunistic infection with a high mortality rate. There are few reports that demonstrate an improvement in the overall prognosis. Furthermore, definite prognostic factors related to patient survival remain unclear. Objective The objective of this study was to evaluate the various clinical factors related to survival of patients with AIFR. Methods This is a retrospective case series with patients treated for AIFR between 1997 and 2013. A total of 45 patients with AIFR were enrolled for analysis. We evaluated demographics, clinical characteristics, and disease course. Results Mean age of patients was 59.6 years. AIFR developed most commonly in patients with immunocompromised host, such as diabetes (n = 23) or hematologic malignancy (n = 17). There were two main genera of fungus, Aspergillus (n = 30) and Mucor (n = 14). Headache, cranial neuropathy, visual loss, and orbital pain were the most common presenting symptoms. Overall survival was 53%. Underlying hematologic malignancy and diabetes were significantly associated with overall survival, and accompanying severe neutropenia and elevated C-reactive protein (CRP) were also related to poor prognosis. Initial presentation with facial swelling, involvement of nasal septum, or shorter symptom duration was also associated with survival reduction. Multivariate analysis revealed that CRP more than 5.50 mg/dL (Hazard ratio [HR], 9.04; p = 003) was an independent prognostic factor in patients with AIFR. Conclusions Overall survival rate remained approximately 50% in patients with AIFR. The prognosis of AIFR is significantly influenced by underlying diseases, accompanying neutropenia, CRP levels, symptom duration, involvement of septum, and the presence of facial swelling. Elevation of CRP, in particular, was an independent predictor of poor outcomes and should be monitored appropriately.

[1]  C. Lelubre,et al.  Interpretation of C-Reactive Protein Concentrations in Critically Ill Patients , 2013, BioMed research international.

[2]  F. Bozza,et al.  The Innate Immune Response in HIV/AIDS Septic Shock Patients: A Comparative Study , 2013, PloS one.

[3]  Timothy L. Smith,et al.  Invasive Fungal Rhinosinusitis , 2013, The Laryngoscope.

[4]  Y. An,et al.  A Novel Model of Invasive Fungal Rhinosinusitis in Rats , 2013, American journal of rhinology & allergy.

[5]  M. Kolář,et al.  Substantially elevated C-reactive protein (CRP), together with low levels of procalcitonin (PCT), contributes to diagnosis of fungal infection in immunocompromised patients , 2013, Supportive Care in Cancer.

[6]  J. Turner,et al.  Survival outcomes in acute invasive fungal sinusitis: A systematic review and quantitative synthesis of published evidence , 2013, The Laryngoscope.

[7]  S. Kim,et al.  Cervicofacial tissue infarction in patients with acute invasive fungal sinusitis: prevalence and characteristic MR imaging findings , 2013, Neuroradiology.

[8]  S. Wise,et al.  Chapter 8: Invasive fungal rhinosinusitis. , 2013, American journal of rhinology & allergy.

[9]  S. Hojker,et al.  Diagnostic accuracy of lipopolysaccharide-binding protein for predicting bacteremia/clinical sepsis in children with febrile neutropenia: comparison with interleukin-6, procalcitonin, and C-reactive protein , 2013, Supportive Care in Cancer.

[10]  K. Ko,et al.  A case of sino-orbital infection caused by the Schizophyllum commune. , 2012, Diagnostic microbiology and infectious disease.

[11]  Yee-Chun Chen,et al.  Invasive fungal sinusitis in patients with hematological malignancy: 15 years experience in a single university hospital in Taiwan , 2011, BMC infectious diseases.

[12]  B. Saedi,et al.  Endoscopic management of rhinocerebral mucormycosis with topical and intravenous amphotericin B. , 2011, The Journal of laryngology and otology.

[13]  J. Hyodo,et al.  Clinical features and outcomes of four patients with invasive fungal sinusitis. , 2011, Auris, nasus, larynx.

[14]  K. Gupta,et al.  Rhino-Orbital-Cerebral Zygomycosis in Solid Organ Transplant Recipients , 2010, Transplantation.

[15]  R. Sindwani An Early Detection Protocol for Invasive Fungal Sinusitis in Neutropenic Patients Successfully Reduces Extent of Disease at Presentation and Long Term Morbidity , 2010 .

[16]  P. Póvoa,et al.  Is C-reactive protein a good prognostic marker in septic patients? , 2009, Intensive Care Medicine.

[17]  Patricia Muñoz,et al.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  A. Süslü,et al.  Acute invasive fungal rhinosinusitis: our experience with 19 patients , 2008, European Archives of Oto-Rhino-Laryngology.

[19]  S. Bhadada,et al.  Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes , 2004, Postgraduate Medical Journal.

[20]  J. DelGaudio,et al.  Invasive Fungal Sinusitis: A 15-Year Review from a Single Institution , 2004, American journal of rhinology.

[21]  P. Hudgins,et al.  Computed tomographic findings in patients with invasive fungal sinusitis. , 2003, Archives of otolaryngology--head & neck surgery.